MedTrace Logo

Early Detection of Pulmonary Exacerbations in Non-cystic Fibrosis Bronchiectasis

NCT06151366 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-02-29

No results posted yet for this study

Summary

The goal of this observational study is to learn about the use of equipment to monitor health at home in participants who have non-cystic fibrosis bronchiectasis. The main question\[s\] it aims to answer are:

* How acceptable participants find using home monitoring equipment.
* To find out if the data collected from home monitoring can help to detect chest infections (exacerbations) before participants get symptoms they are aware of.

Participants will be provided with -

* a handheld spirometer to record FEV1 (lung function)
* a Fitbit, or other compatible activity monitor, to record activity and heart rate
* a saturation monitor that fits painlessly on the end of the finger to record oxygen levels
* weighing scales to record weight
* a mini freezer and pre-labelled sample containers to store a daily sputum sample. There is enough room in the freezers for samples to be brought to routine clinic visits. We will provide a cool bag and freezer packs for this. A courier collection of the samples can be arranged if necessary.

Participants will be encouraged to perform lung function, activity and oxygen levels at least 4 x per week.

Participants will be guided through how to set up and use each piece of equipment by the research team. The devices all connect to a smartphone app called Breathe RM (Remote Monitor,) which is free to download, via Bluetooth. Once set up using the home monitoring devices and adding notes to the app should take no more than 15 minutes per day.

Participants will be asked to record in the app -

* episodes of pulmonary exacerbation that require antibiotic treatment
* their coughing and wellness scores daily

Conditions

  • Non-cystic Fibrosis Bronchiectasis

Interventions

OTHER

non interventional

non interventional

Sponsors & Collaborators

  • LifeArc

    collaborator OTHER

  • Papworth Hospital NHS Foundation Trust

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-31
Primary Completion
2024-10-31
Completion
2024-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06151366 on ClinicalTrials.gov